echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > [Image Note] Reversible posterior encephalopathy syndrome (PRES)

    [Image Note] Reversible posterior encephalopathy syndrome (PRES)

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Overview — PRES

    Definition: is a clinical-imaging syndrome
    with reversible neurological lesions and specific radiographic findings.

    Age of onset: can occur at any age, more common in
    young women.

    Clinical manifestations: Acute or subacute onset depending on the location and extent of injury, mainly including: sudden increase in blood pressure, headache, nausea, vomiting, blurred vision, seizures, impaired consciousness and mental abnormalities
    .
    Timely and effective treatment of the cause is found, and clinical symptoms and imaging manifestations can be completely restored or restored to the pre-onset level
    .

    Laboratory tests: elevated LDH levels can precede clinical and imaging findings and can be used to detect the degree of
    cerebral edema in patients with PRES.

    pathogen

    Common causes

    Malignant hypertension (most common)

    Pregnancy and perinatal eclampsia, preeclampsia, etc

    Various serious kidney diseases (such as acute glomerulonephritis, chronic renal insufficiency, etc.
    )

    Application of immunosuppressive drugs and cytotoxic drugs (immunoglobulin, interferon, cyclosporine, etc.
    ) after organ and tissue transplantation

    Oncology chemotherapy drugs (ifosfamide, cisplatin, etc.
    )

    Rare causes

    Connective tissue diseases (e.
    g.
    , SLE, nodular arteritis, Behcet's disease)

    Hemolytic uremic syndrome

    Multi-organ failure

    Thrombotic thrombocytopenic purpura

    Massive blood transfusions

    AIDS and alcoholism

    Pathological mechanism

    Cerebral perfusion pressure breakthrough theory: (most accepted)

    Blood pressure rises sharply, exceeding the upper limit of cerebral vascular self-regulation, cerebral vascular passive dilation, cerebral perfusion pressure increases, capillary endothelial cells are tightly connected and open, capillary permeability increases, the blood-brain barrier is damaged, plasma components penetrate into the brain parenchyma, resulting in vasogenic edema or petechial hemorrhage without cerebral infarction
    .
    White matter is looser than gray matter, and liquid is easy to retain; The sympathetic nerve fibers of the posterior circulation vessels are less distributed and easy to expand, so vasogenic cerebral edema is more likely to appear in the back of the
    brain.

    The theory of vasospasm

    Vascular endothelial injury theory

    Radiographic findings

    Place:

    Typical site: parieto-occipital lobe, may be associated with cortical involvement
    .

    Atypical sites: involvement beyond the parietal occipital area (eg, only frontal and temporal lobes; posterior frontal lobe and corpus callosum pressure; It can also involve only the brainstem, cerebellum, basal ganglia, thalamus, etc.
    )

    Distribution: symmetrical on both sides, white matter is heavier than gray matter, and the posterior cycle is heavier than the anterior circulation
    .

    CT findings: lack of specificity, mostly manifested as bilateral parietal occipital lobes symmetrical patchy low-density opacities, no mass effect
    .

    MR performance:

    T1 and other low intensity, T2 and FLAIR high intensity, FLAIR is more sensitive, can find cortical lesions
    .
    DWI is low or high signal, and ADC is high signal
    .
    There is generally no reinforcement after enhancement, but due to the destruction of the blood-brain barrier, strengthening
    is occasionally seen.
    May be combined with bleeding, mostly oozing, multiple or single primary swelling or microbleeding
    .
    MRV shows patency of cerebral veins and sinuses without stenosis, abnormal dilation, and signs of thrombosis
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.